QRskin

Executive Summary

QRskin is a Munich-based digital health company founded in 2018 that develops AI-powered solutions for dermatology. Its platform integrates automated skin analysis with telemedicine services, enabling remote diagnosis and management of skin diseases. The company aims to improve access to dermatological care by leveraging artificial intelligence to analyze skin images and connect patients with specialists virtually. Although QRskin operates in the rapidly growing digital dermatology market, it remains at an early stage with no disclosed funding, commercial products, or regulatory approvals. The company's technology has potential to address healthcare inefficiencies, but limited public information on clinical validation, revenue, or partnerships makes it difficult to assess traction. Market trends favor digital health adoption, and QRskin's focus on AI-driven dermatology aligns with increasing demand for accessible care. However, the lack of concrete milestones and competitive pressures from established tele-dermatology platforms present risks. The company's ability to secure funding, achieve regulatory clearance, and demonstrate clinical efficacy will be critical for its growth.

Upcoming Catalysts (preview)

• Q4 2026Series A Funding Round60% success
• Q2 2027CE Marking for AI Skin Analysis Software50% success
• 2027Clinical Study Publication Demonstrating Diagnostic Accuracy40% success